Abstract
In this study, we investigated the role of E1AF, a member of ets family transcription factor, in the acquisition of metastatic capacity by non-metastatic mouse fibrosarcoma cell clone, QR-32. The QR-32 cell clone grows progressively after co-implantation with gelatin sponge in syngeneic C57BL/6 mice. The cell lines (QRsP) established from arising tumors after the co-implantation exhibited enhanced tumorigenicity and pulmonary metastasis in vivo as compared with parent QR-32 cells. The enhanced pulmonary metastasis of QRsP cells was correlated well with augmented production of matrix metalloproteinase-2 (MMP-2) and increased expression of membrane-type 1-MMP (MT1-MMP). The QRsP cells also acquired higher chemokinetic activities to fibronectin and higher invasive activities through a reconstituted basement membrane. Furthermore we observed the elevated mRNA expression of E1AF in QRsP cells compared to parent QR-32 cells. Therefore, we transfected QR-32 cells with E1AF cDNA. Overexpression of E1AF in the QR-32 cells resulted in the induction of MT1-MMP expression and converting an exogenously added precursor MMP-2 into active form. E1AF transfectants exhibited more motile and invasive activities, and moderately increased pulmonary metastatic activities than parental QR-32 cells in vivo, although their metastatic activities were lower than those of QRsP cells. These findings suggest that the increased expression of E1AF in fibrosarcoma contributes to invasive phenotypes including MT1-MMP expression and enhanced cell migration, but not sufficient for exhibiting highly metastatic activity in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN. . 1987 Cancer Res. 47: 3239–3245.
Ascher NL, Ferguson RM, Hoffman R and Simmons RL. . 1979 Transplantation 27: 254–259.
Baert JL, Monte D, Musgrove EA, Albagli O, Sutherland RL and Launoit Y. . 1997 Int. J. Cancer 70: 590–597.
Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, Decarlo A and Engler JA. . 1993 Crit. Rev. Oral Biol. Med. 4: 197–250.
Brooks PC, Stromblad S, Sanders LC, Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP and Cheresh DA. . 1996 Cell 85: 683–693.
Cerutti P and Trump BF. . 1991 Cancer Cells 3: 1–7.
Chambers AF and Matrisian LM. . 1997 J. Natl. Cancer Inst. 89: 1260–1270.
Chen JH, Vercamer C, Li Z, Paulin D, Vandenbunder B and Stehelin D. . 1996 Oncogene 13: 1667–1675.
Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He C, Bauer EA and Goldberg GI. . 1988 J. Biol. Chem. 263: 6579–6587.
Crawford HC and Matrisian LM. . 1996 Enzyme Proteine 49: 20–37.
Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG and Quaranta V. . 1997 Science 277: 225–228.
Higashino F, Yoshida K, Noumi T, Seiki M and Fujinaga K. . 1995 Oncogene 10: 1461–1463.
Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M and Okada Y. . 1996 Cancer Res. 56: 2707–2710.
Imai K, Ohta S, Matsumoto T, Fujimoto N, Sato H, Seiki M and Okada Y. . 1997 Am. J. Pathol. 151: 245–256.
Kadono Y, Okada Y, Namiki M, Seiki M and Sato H. . 1998 Cancer Res. 58: 2240–2244.
Kaya M, Yoshida K, Higashino F, Mitaka T, Ishii S and Fujinaga K. . 1996 Oncogene 12: 221–227.
Kohn EC, Jacobs W, Kim YS, Alessando R, Stetler-Stevenson WG and Liotta LA. . 1994 J. Biol. Chem. 269: 21505–21511.
Liotta LA, Steeg PS and Stetler-Stevenson WG. . 1991 Cell 64: 327–336.
Lohi J, Lehti K, Westermarck J, Kahari VM and Keski-Oja J. . 1996 Eur. J. Biochem. 239: 239–247.
Matrisian LM. . 1994 Annu. N. Y. Acad. Sci. 732: 42–50.
Mignatti P and Rifkin NB. . (1993). Physiol. Rev. 73: 161–195.
Monsky WL, Kelly T, Lin C, Yeh Y, Stetler-Stevenson WG, Mueller SC and Chen W. . 1993 Cancer Res. 53: 3159–3164.
O'Hagan RC, Tozer RG, Symons M, McCormick F and Hassell JA. . 1996 Oncogene 13: 1323–1333.
Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M and Okada Y. . 1997 J. Biol. Chem. 272: 2446–2451.
Okada F, Hosokawa M, Hamada J, Hasegawa J, Kato M, Mizutani M, Ren J, Takeichi N and Kobayashi H. . 1992 Br. J. Cancer 66: 635–639.
Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P and Basset P. . 1995 Proc. Natl. Acad. Sci. USA 92: 2730–2734.
Overall CM. . 1994 Annu. N. Y. Acad. Sci. 732: 51–64.
Overall CM and Sodek J. . 1990 J. Biol. Chem. 265: 21141–21151.
Overall CM, Wrana JL and Sodek J. . 1991 J. Biol. Chem. 266: 14064–14071.
Rosen GM, Pou S, Ramos CL, Cohen MS and Britigan BE. . 1995 FASEB J. 9: 200–209.
Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H and Larjava H. . 1991 J. Biol. Chem. 266: 11436–11441.
Sato H, Takeshi T, Kinoshita T, Imai K, Okada Y, Stetler-Stevenson WG, Seiki M. . 1996 FEBS Letters 385: 238–240.
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M. . 1994 Nature 370: 61–65.
Shindoh M, Higashino F, Kaya M, Yasuda M, Funaoka K, Hanzawa M, Hida K, Kohgo T, Amemiya A, Yoshida K and Fujinaga K. . 1996 Am. J. Pathol. 148: 693–700.
Stetler-Stevenson WG, Liotta LA and Kleiner JRDE. . 1993 FASEB J. 7: 1434–1441.
Taguchi K, Yoshida K, Sasaki F and Fujinaga K. . 1997 Jpn. J. Cancer Res. 88: 394–400.
Trimble MS, Xin J, Guy CT, Muller WJ and Hassell JA. . 1993 Oncogene 8: 3037–3042.
Turck J, Pollock AS, Lee LK, Marti HP and Lovett DH. . 1996 J. Biol. Chem. 271: 15074–15083.
Wasylyk B, Hahn SL and Giovane A. . 1993 Eur. J. Biochem. 211: 7–18.
Weitzman SA and Gordon LI. . 1990 Blood 76: 655–663.
Acknowledgements
This work was supported in part by a Grants-in-Aid for Cancer Research from the Japanese Ministry of Health and Welfare. We thank Prof Motoharu Seiki of Tokyo University for his comments and discussions and Miss Masako Yanome for her kindly revising the English of the manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Habelhah, H., Okada, F., Kobayashi, M. et al. Increased E1AF expression in mouse fibrosarcoma promotes metastasis through induction of MT1-MMP expression. Oncogene 18, 1771–1776 (1999). https://doi.org/10.1038/sj.onc.1202465
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202465
Keywords
This article is cited by
-
Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition
Oncogenesis (2012)
-
PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma
British Journal of Cancer (2011)
-
Inhibition of adhesion and proliferation of peritoneally disseminated tumor cells by pegylated catalase
Clinical & Experimental Metastasis (2006)
-
Membrane-type-1 matrix metalloproteinase confers tumorigenicity on nonmalignant epithelial cells
Oncogene (2005)
-
Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo
Journal of Cancer Research and Clinical Oncology (2005)